| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.49 | 0.1 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.25 | 0.4 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.19 | 0.0001 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.18 | 0.0005 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.14 | 9e-05 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.14 | 0.08 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.13 | 0.003 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.12 | 0.02 |